MRNS

Health Care Sector Update for 09/11/2017: MRNS

Top Health-care stocks:

JNJ: flat

PFE: +0.2%

ABT: flat

MRK: flat

AMGN: +1.0%

Health-care shares were mainly unchanged in pre-market trade on Monday.

In health-care stocks news, Marinus Pharmaceuticals ( MRNS ) said top-line data from the phase 2 study in patients with CDKL5 disorder support advancing ganaxolone into a definitive late-stage clinical trial.

Shares in the company were 37.8% higher at $4.30 in early trade. The stock has traded between $0.82 and $3.25 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.